Antiarrhythmic drugs and anaesthesia. Part 2: pharmacotherapy.
作者信息
Kim C J, Lever N, Cooper J O
机构信息
Auckland City Hospital (Te Toka Tumai), Auckland, New Zealand.
University of Auckland, Auckland, New Zealand.
出版信息
BJA Educ. 2023 Feb;23(2):52-60. doi: 10.1016/j.bjae.2022.11.005. Epub 2022 Dec 21.
Abstract
摘要
相似文献
1
Antiarrhythmic drugs and anaesthesia. Part 2: pharmacotherapy.抗心律失常药物与麻醉。第2部分：药物治疗。
BJA Educ. 2023 Feb;23(2):52-60. doi: 10.1016/j.bjae.2022.11.005. Epub 2022 Dec 21.
2
Antiarrhythmic drugs and anaesthesia: part 1. mechanisms of cardiac arrhythmias.抗心律失常药物与麻醉：第1部分。心律失常的机制。
BJA Educ. 2023 Jan;23(1):8-16. doi: 10.1016/j.bjae.2022.11.001. Epub 2022 Dec 5.
3
Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.心律失常的药物治疗——临床医生的基础科学
Pacing Clin Electrophysiol. 2009 Nov;32(11):1454-65. doi: 10.1111/j.1540-8159.2009.02526.x. Epub 2009 Sep 10.
4
Future of antiarrhythmic drugs.抗心律失常药物的未来。
Curr Opin Cardiol. 2006 Jul;21(4):361-7. doi: 10.1097/01.hco.0000231407.61683.05.
5
Model systems for the discovery and development of antiarrhythmic drugs.用于抗心律失常药物发现与开发的模型系统。
Prog Biophys Mol Biol. 2008 Oct-Nov;98(2-3):328-39. doi: 10.1016/j.pbiomolbio.2008.10.009. Epub 2008 Nov 11.
6
Predicting the recurrence of ventricular tachyarrhythmias from T-wave alternans assessed on antiarrhythmic pharmacotherapy: a prospective study in patients with dilated cardiomyopathy.基于抗心律失常药物治疗评估的T波电交替预测扩张型心肌病患者室性快速性心律失常复发：一项前瞻性研究
Ann Noninvasive Electrocardiol. 2001 Jul;6(3):203-8. doi: 10.1111/j.1542-474x.2001.tb00109.x.
7
Clinical types of proarrhythmic response to antiarrhythmic drugs.抗心律失常药物致心律失常反应的临床类型。
Am J Cardiol. 1987 Apr 30;59(11):2E-9E. doi: 10.1016/0002-9149(87)90195-0.
8
Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?抗心律失常药物对犬心室心律失常模型的影响：药物的哪些电生理特性与其有效性相关？
Cardiovasc Drugs Ther. 1991 Aug;5 Suppl 4:805-17. doi: 10.1007/BF00120829.
9
New directions in the development of antiarrhythmic drugs.抗心律失常药物研发的新方向
J Clin Pharmacol. 1984 Jul;24(7):333-41. doi: 10.1002/j.1552-4604.1984.tb01843.x.
10
Use of antiarrhythmic drugs in elderly patients.老年患者抗心律失常药物的应用。
J Geriatr Cardiol. 2011 Sep;8(3):184-94. doi: 10.3724/SP.J.1263.2011.00184.
本文引用的文献
1
Antiarrhythmic drugs and anaesthesia: part 1. mechanisms of cardiac arrhythmias.抗心律失常药物与麻醉：第1部分。心律失常的机制。
BJA Educ. 2023 Jan;23(1):8-16. doi: 10.1016/j.bjae.2022.11.001. Epub 2022 Dec 5.
2
Use of Preoperative Single Dose Ivabradine for Perioperative Hemodynamic Stabilization During Non-Cardiac Elective Surgery Under General Anaesthesia: A Pilot Study.术前单次静脉注射伊伐布雷定用于全身麻醉下非心脏择期手术围手术期血流动力学稳定的研究：一项初步研究。
J Clin Med Res. 2021 Jun;13(6):343-354. doi: 10.14740/jocmr4441. Epub 2021 Jun 25.
3
Modernized Classification of Cardiac Antiarrhythmic Drugs.心脏抗心律失常药物的现代化分类。
Circulation. 2018 Oct 23;138(17):1879-1896. doi: 10.1161/CIRCULATIONAHA.118.035455.
4
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).抗心律失常药物——临床应用与临床决策：欧洲心律协会（EHRA）和欧洲心脏病学会（ESC）心血管药理学工作组的共识文件，得到心律学会（HRS）、亚太心律学会（APHRS）和国际心血管药物治疗学会（ISCP）认可。
Europace. 2018 May 1;20(5):731-732an. doi: 10.1093/europace/eux373.
5
Ranolazine: A Contemporary Review.雷诺嗪：当代综述。
J Am Heart Assoc. 2016 Mar 15;5(3):e003196. doi: 10.1161/JAHA.116.003196.
6
Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery.主要非心脏手术后与术后心房颤动相关的发生率、预测因素和结局。
Am Heart J. 2012 Dec;164(6):918-24. doi: 10.1016/j.ahj.2012.09.004. Epub 2012 Oct 26.
7
Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery.雷诺嗪预防冠状动脉血运重建术患者术后心房颤动的效果。
Curr Vasc Pharmacol. 2013 Nov;11(6):988-91. doi: 10.2174/157016111106140128123506.
8
Cardiac ion channels.心脏离子通道
Circ Arrhythm Electrophysiol. 2009 Apr;2(2):185-94. doi: 10.1161/CIRCEP.108.789081.
9
Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).一种新型抗心绞痛药物在重度慢性稳定性心绞痛患者中的长期安全性：雷诺嗪开放标签试验（ROLE）。
J Am Coll Cardiol. 2007 Mar 13;49(10):1027-34. doi: 10.1016/j.jacc.2006.10.067. Epub 2007 Feb 26.
10
Atrial fibrillation following cardiac surgery.心脏手术后的心房颤动。
Can J Cardiol. 2005 Sep;21 Suppl B:45B-50B.
Zotero 插件